Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prediabetes, type 2 diabetes mellitus and risk of Parkinson’s disease: A population-based cohort study
Almudena Sánchez‐Gómez, Yesika Díaz, Talita Duarte‐Salles, et al.
Parkinsonism & Related Disorders (2021) Vol. 89, pp. 22-27
Closed Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

Epidemiology of Parkinson’s Disease: An Update
Juan R. Deliz, Caroline M. Tanner, Paulina González-Latapí
Current Neurology and Neuroscience Reports (2024) Vol. 24, Iss. 6, pp. 163-179
Closed Access | Times Cited: 16
Glucose metabolism impairment in Parkinson’s disease
Chengcheng Dai, Changhong Tan, Lili Zhao, et al.
Brain Research Bulletin (2023) Vol. 199, pp. 110672-110672
Open Access | Times Cited: 38
NF‐κB/NLRP3 inflammasome axis and risk of Parkinson's disease in Type 2 diabetes mellitus: A narrative review and new perspective
Mohammed Alrouji, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Journal of Cellular and Molecular Medicine (2023) Vol. 27, Iss. 13, pp. 1775-1789
Open Access | Times Cited: 32
Diabetes mellitus, prediabetes and the risk of Parkinson’s disease: a systematic review and meta-analysis of 15 cohort studies with 29.9 million participants and 86,345 cases
Dagfinn Aune, Sabrina Schlesinger, Yahya Mahamat‐Saleh, et al.
European Journal of Epidemiology (2023) Vol. 38, Iss. 6, pp. 591-604
Open Access | Times Cited: 30
Type 2 Diabetes and Parkinson's Disease: A Focused Review of Current Concepts
Patrick W. Cullinane, Eduardo De Pablo‐Fernández, Annekatrin König, et al.
Movement Disorders (2022) Vol. 38, Iss. 2, pp. 162-177
Closed Access | Times Cited: 33
Association between Parkinson’s Disease and Diabetes Mellitus: From Epidemiology, Pathophysiology and Prevention to Treatment
Haiyang Yu, Tong Sun, He Xin, et al.
Aging and Disease (2022) Vol. 13, Iss. 6, pp. 1591-1591
Open Access | Times Cited: 31
Diabetes: a tipping point in neurodegenerative diseases
José A. Santiago, M. Ganesh Karthikeyan, Madison Lackey, et al.
Trends in Molecular Medicine (2023) Vol. 29, Iss. 12, pp. 1029-1044
Open Access | Times Cited: 19
Mercury is present in neurons and oligodendrocytes in regions of the brain affected by Parkinson’s disease and co-localises with Lewy bodies
Roger Pamphlett, David Bishop
PLoS ONE (2022) Vol. 17, Iss. 1, pp. e0262464-e0262464
Open Access | Times Cited: 27
Causal relationships between type 1 diabetes mellitus and Alzheimer’s disease and Parkinson’s disease: a bidirectional two-sample Mendelian randomization study
Chaofan Geng, Ke Meng, Bo Zhao, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 5
The Contribution of Type 2 Diabetes to Parkinson’s Disease Aetiology
Samo Ribarič
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4358-4358
Open Access | Times Cited: 5
Metabolism and metabolomics in senescence, aging, and age-related diseases: a multiscale perspective
Ziyi Wang, Hongying Zhu, Wei Xiong
Frontiers of Medicine (2025)
Closed Access
Association of pre-diabetes with the risks of adverse health outcomes and complex multimorbidity: evidence from population-based studies in the NIS and UK Biobank
Yiman Wu, Xiude Fan, Yingzhou Shi, et al.
BMJ Public Health (2025) Vol. 3, Iss. 1, pp. e001539-e001539
Open Access
Exploring the link between estimated glucose disposal rate and Parkinson’s disease: cross-sectional and mortality analysis of NHANES 2003–2016
Xiaoting Li, Zhaohao Zeng
Frontiers in Aging Neuroscience (2025) Vol. 17
Open Access
Association between diabetes mellitus, prediabetes and risk, disease progression of Parkinson's disease: A systematic review and meta-analysis
Qifan Zhong, Shenglong Wang
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 12
Parkinson's disease and glucose metabolism impairment
Liangjing Chen, Chunyu Wang, Lixia Qin, et al.
Translational Neurodegeneration (2025) Vol. 14, Iss. 1
Open Access
Molecular Mechanisms of Amylin Turnover, Misfolding and Toxicity in the Pancreas
Diti Chatterjee Bhowmick, Zhanar Kudaibergenova, Lydia Burnett, et al.
Molecules (2022) Vol. 27, Iss. 3, pp. 1021-1021
Open Access | Times Cited: 18
Potential Protective Link Between Type I Diabetes and Parkinson's Disease Risk and Progression
Konstantin Senkevich, Paria Alipour, Ekaterina А. Chernyavskaya, et al.
Movement Disorders (2023) Vol. 38, Iss. 7, pp. 1350-1355
Open Access | Times Cited: 10
The association between type 2 diabetes mellitus and Parkinson's disease; a systematic review and meta-analysis
Maria Anna Bantounou, Khalisah Shoaib, Adele Mazzoleni, et al.
Brain Disorders (2024) Vol. 15, pp. 100158-100158
Open Access | Times Cited: 3
Epidemiological Evidence for an Immune Component of Parkinson’s Disease
Paulina González-Latapí, Connie Marras
Journal of Parkinson s Disease (2022) Vol. 12, Iss. s1, pp. S29-S43
Open Access | Times Cited: 14
Nanocarriers to mediate the pathways from diabetes toward Parkinson's disease
Sourav De, Yung‐Chih Kuo
Journal of the Taiwan Institute of Chemical Engineers (2024) Vol. 157, pp. 105401-105401
Closed Access | Times Cited: 2
Frailty and Parkinson’s disease: the role of diabetes mellitus
Klara Komici, Antonella Pansini, Leonardo Bencivenga, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 2
Targeting Glucose Metabolism: A Novel Therapeutic Approach for Parkinson’s Disease
Tanvir Ahmed, Junghyun Jo, Sang Myun Park
Cells (2024) Vol. 13, Iss. 22, pp. 1876-1876
Open Access | Times Cited: 2
Associations Between Diabetic Retinopathy and Parkinson's Disease: Results From the Catalonian Primary Care Cohort Study
Dı́dac Mauricio, Bogdan Vlacho, Joan Barrot de la Puente, et al.
Frontiers in Medicine (2022) Vol. 8
Open Access | Times Cited: 9
Association between prediabetes and cognitive function in Parkinson's disease
Joah Park, Seohee Choi, Ryul Kim
Brain and Behavior (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 9
Repurposing the inhibitors of MMP-9 and SGLT-2 against ubiquitin specific protease 30 in Parkinson’s disease: computational modelling studies
Mohammed M. Alshehri, Ammar Usman Danazumi, Mohammed Kanan Alshammari, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 3, pp. 1307-1318
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top